{"content":"<li class=\"n-box-item date-title\" data-end=\"1384577999\" data-start=\"1384491600\" data-txt=\"Friday, December 20, 2019\">Friday, November 15, 2013</li><li class=\"n-box-item sa-box-item\" data-id=\"1417152\" data-ts=\"1384555364\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1417152-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After-hours Gainers / Losers</a></h4><ul><li><b>After-hours Top Gainers, as of 5:15 p.m.:</b> <a href='https://seekingalpha.com/symbol/TTS' title='Tile Shop Holdings, Inc.'>TTS</a> <font color='green'>+4.1%</font>. <a href='https://seekingalpha.com/symbol/OTIV' title='On Track Innovations Ltd'>OTIV</a> <font color='green'>+2.7%</font>. <a href='https://seekingalpha.com/symbol/IRDM' title='Iridium Communications Inc'>IRDM</a> <font color='green'>+2.3%</font>. <a href='https://seekingalpha.com/symbol/MITL' title='Mitel Networks Corporation'>MITL</a> <font color='green'>+2.1%</font>. <a href='https://seekingalpha.com/symbol/BTH' title='Blyth, Inc.'>BTH</a> <font color='green'>+2.1%</font>.</li><li><b>After-hours Top Losers, as of 5.15 p.m.:</b> <a href='https://seekingalpha.com/symbol/AWAY' title='HomeAway, Inc.'>AWAY</a> <font color='red'>-6.0%</font>. <a href='https://seekingalpha.com/symbol/FRAN' title='Francesca&#39;s Holdings Corp.'>FRAN</a> <font color='red'>-2.7%</font>. <a href='https://seekingalpha.com/symbol/EGLE' title='Eagle Bulk Shipping Inc.'>EGLE</a> <font color='red'>-2.7%</font>. <a href='https://seekingalpha.com/symbol/MWE' title='MarkWest Energy Partners, L.P.'>MWE</a> <font color='red'>-2.5%</font>. <a href='https://seekingalpha.com/symbol/IBKR' title='Interactive Brokers Group, Inc.'>IBKR</a> <font color='red'>-2.4%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"1417152\" data-linked=\"After-hours Gainers / Losers\" data-tweet=\"$TTSH $OTIV $IRDM - After-hours Gainers / Losers https://seekingalpha.com/news/1417152-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1417152-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1417032\" data-ts=\"1384551312\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PANW\" target=\"_blank\">PANW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1417032-palo-alto-closes-up-sharply-as-juniper-hearing-takes-place\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Palo Alto closes up sharply as Juniper hearing takes place</a></h4><ul>     <li>Palo Alto (<a href=\"https://seekingalpha.com/symbol/PANW\" title=\"Palo Alto Networks\">PANW</a> <font color=\"green\">+8.5%</font>) shares surged into the close on a day when a major hearing took place for Juniper's (<a href=\"https://seekingalpha.com/symbol/JNPR\" title=\"Juniper Networks\">JNPR</a> <font color=\"green\">+2.2%</font>) patent suit against its share-gaining firewall rival. Attorney/trader <a href=\"https://twitter.com/danravicher\" target=\"_blank\">Daniel B. Ravicher</a>, who attended the hearing, suggests the proceedings went in Palo Alto's favor, with the judge presiding over the dispute questioning the breadth of Juniper's patent claims.</li>\n<li>As SA contributor <a href=\"https://seekingalpha.com/article/1819652-juniper-networks-vs-palo-alto-networks\" target=\"_blank\">Markman Advisors</a> has covered in detail, today's hearing relates to claim construction - the court rules on the scope of Juniper's infringement claims for six patents - as well as Juniper's request for a summary judgment of infringement for multiple patents.</li>\n<li>Palo Alto investors <a href=\"https://seekingalpha.com/currents/post/1091732\" target=\"_blank\">have been nervous</a> for a while about the Juniper suit, which is related to IP Palo Alto's founders developed while working at Juniper-acquired NetScreen.</li>\n<li>\n<a href=\"http://finance.yahoo.com/news/juniper-may-hold-advantage-over-130140678.html\" target=\"_blank\">Cowen</a> has argued Markman filings leave Juniper well-positioned. <a href=\"http://www.streetinsider.com/Analyst+Comments/Palo+Alto+%28PANW%29+Investors+Overly+Concerned+About+Litigation%2C+Thinks+Goldman+Sachs+Analyst/8880756.html\" target=\"_blank\">Goldman </a>thinks the amount of lawsuit-related \"overhang\" that has been priced into Palo Alto's shares runs well into ten figures.</li>\n<li>Palo Alto <a href=\"https://seekingalpha.com/currents/post/1306642\" target=\"_blank\">filed a countersuit</a> against Juniper in September.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1417032\" data-linked=\"Palo Alto closes up sharply as Juniper hearing takes place\" data-tweet=\"$PANW $PANW $JNPR - Palo Alto closes up sharply as Juniper hearing takes place https://seekingalpha.com/news/1417032-palo-alto-closes-up-sharply-as-juniper-hearing-takes-place?source=tweet\" data-url=\"https://seekingalpha.com/news/1417032-palo-alto-closes-up-sharply-as-juniper-hearing-takes-place\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1417002\" data-ts=\"1384550541\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1417002-weekly-etf-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weekly ETF Gainers / Losers</a></h4><ul>     <li> <b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/fxi\" title=\"iShares China Large-Cap ETF\">FXI</a> <font color=\"green\">+4.34%</font>. <a href=\"https://seekingalpha.com/symbol/ewj\" title=\"iShares MSCI Japan ETF\">EWJ</a> <font color=\"green\">+4.26%</font>. <a href=\"https://seekingalpha.com/symbol/xhb\" title=\"SPDR Homebuilders ETF\">XHB</a> <font color=\"green\">+3.94%</font>. <a href=\"https://seekingalpha.com/symbol/brf\" title=\"Market Vectors Brazil Small-Cap ETF\">BRF</a> <font color=\"green\">+3.69%</font>. <a href=\"https://seekingalpha.com/symbol/ewz\" title=\"iShares MSCI Brazil Capped ETF\">EWZ</a> <font color=\"green\">+3.40%</font>.  </li>\n<li> <b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/sivr\" title=\"ETFS Silver Trust ETF\">SIVR</a> <font color=\"red\">-3.44%</font>. <a href=\"https://seekingalpha.com/symbol/slv\" title=\"iShares Silver Trust ETF\">SLV</a> <font color=\"red\">-3.38%</font>. <a href=\"https://seekingalpha.com/symbol/pslv\" title=\"Sprott Physical Silver Trust\">PSLV</a> <font color=\"red\">-3.36%</font>. <a href=\"https://seekingalpha.com/symbol/vxx\" title=\"iPath S&amp;P 500 VIX Short-Term Futures ETN\">VXX</a> <font color=\"red\">-3.22%</font>. <a href=\"https://seekingalpha.com/symbol/fxy\" title=\"CurrencyShares Japanese Yen Trust ETF\">FXY</a> <font color=\"red\">-1.09%</font>. </li> </ul><div class=\"tiny-share-widget\" data-id=\"1417002\" data-linked=\"Weekly ETF Gainers / Losers\" data-tweet=\"$FXI $EWJ $XHB - Weekly ETF Gainers / Losers https://seekingalpha.com/news/1417002-weekly-etf-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1417002-weekly-etf-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1416902\" data-ts=\"1384548898\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FONR\" target=\"_blank\">FONR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1416902-fonar-logs-big-gains-after-fq1-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fonar logs big gains after FQ1 report</a></h4><ul>\n<li>Shares of Fonar Corporation (<a href=\"https://seekingalpha.com/symbol/FONR\" title=\"Fonar Corporation\">FONR</a> <font color=\"green\">+60.1%</font>) are in the midst of a spectacular rally on the heels of the company's FQ1 results (out this morning).</li>\n<li>Revenue for the period rose 77% Y/Y, while diluted net income jumped 68%.</li>\n<li>Income from operations doubled.</li>\n<li>Cash as of September 30: $9.2M (+17% Q/Q).</li>\n<li>\"By combining resources ... we will enjoy the benefits  of economies of scale, shared administrative and technical expertise and  capabilities, and joint marketing strategies,\"  chairman Raymond Damadian said, commenting on the HDM acquisition which, as expected, has been \"a significant source of profitability.\" (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1416902\" data-linked=\"Fonar logs big gains after FQ1 report\" data-tweet=\"$FONR - Fonar logs big gains after FQ1 report https://seekingalpha.com/news/1416902-fonar-logs-big-gains-after-fq1-report?source=tweet\" data-url=\"https://seekingalpha.com/news/1416902-fonar-logs-big-gains-after-fq1-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1416872\" data-ts=\"1384548422\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACTG\" target=\"_blank\">ACTG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1416872-acacia-bounces-after-announcing-70m-buyback\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Acacia bounces after announcing $70M buyback</a></h4><ul>\n<li>After closing yesterday near its 52-week low of $14.08, Acacia (<a href=\"https://seekingalpha.com/symbol/ACTG\" title=\"Acacia Research Corporation\">ACTG</a> <font color=\"green\">+5.8%</font>) is rallying on news its board has authorized a $70M buyback, good for repurchasing 9% of outstanding shares at current levels. (PR)</li>\n<li>Acacia has $285M in cash/equivalents on its balance sheet to finance the buybacks with, and no debt to worry about. Shares of the IP licensing firm remain <font color=\"red\">down 41%</font> YTD, thanks to <a href=\"https://seekingalpha.com/currents/post/1336062\" target=\"_blank\">earnings misses</a> and concerns about <a href=\"https://seekingalpha.com/currents/post/1062941\" target=\"_blank\">regulatory actions</a> against patent trolls.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1416872\" data-linked=\"Acacia bounces after announcing $70M buyback\" data-tweet=\"$ACTG - Acacia bounces after announcing $70M buyback https://seekingalpha.com/news/1416872-acacia-bounces-after-announcing-70m-buyback?source=tweet\" data-url=\"https://seekingalpha.com/news/1416872-acacia-bounces-after-announcing-70m-buyback\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:47 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1416862\" data-ts=\"1384547319\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FNMA\" target=\"_blank\">FNMA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1416862-catches-aside-plan-for-frannie-could-just-work\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Catches aside, plan for Frannie could just work</a></h4><ul>\n<li>Bruce Berkowitz's presentation of his plan to purchase and recapitalize the mortgage insurance business of Fannie Mae (<a href=\"https://seekingalpha.com/symbol/FNMA\" title=\"Fannie Mae\">OTCQB:FNMA</a> <font color=\"green\">+10.5%</font>) and Freddie Mac (<a href=\"https://seekingalpha.com/symbol/FMCC\" title=\"Freddie Mac\">OTCQB:FMCC</a> <font color=\"green\">+8.6%</font>) cleverly leads off with quotes from politicians - including the president and FHFA chief Ed DeMarco - calling for private capital to play a larger role in the mortgage market.</li>\n<li>\n<a href=\"http://online.wsj.com/public/resources/documents/FairholmeOffer.pdf\" target=\"_blank\">Presentation slides here</a>.</li>\n<li>Bloomberg's Matt Levine's<a href=\"http://www.bloomberg.com/news/2013-11-14/crazy-plan-to-privatize-fannie-is-pretty-good-.html\" target=\"_blank\"> review here</a>.</li>\n<li>His plan actually makes pretty good sense, but with one catch: The conversion of preferred stock for equity in a new, debt-free company with $52B in assets represents somewhere in the area of a $20B-$30B windfall for those owning the preferred.</li>\n<li>The plan also talks about bringing competition to the business even as it creates a new cheaply-capitalized company $52B in size. Far smaller competitors can hardly hope to match.</li>\n<li>Earlier: <a href=\"https://seekingalpha.com/currents/post/1415732\" target=\"_blank\">Ackman joins the fray</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1416862\" data-linked=\"Catches aside, plan for Frannie could just work\" data-tweet=\"$FNMA $FNMA $FMCC - Catches aside, plan for Frannie could just work https://seekingalpha.com/news/1416862-catches-aside-plan-for-frannie-could-just-work?source=tweet\" data-url=\"https://seekingalpha.com/news/1416862-catches-aside-plan-for-frannie-could-just-work\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1416822\" data-ts=\"1384546156\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TROV\" target=\"_blank\">TROV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1416822-trovagene-manages-rally-after-q3-results-aegis-remains-bullish\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trovagene manages rally after Q3 results; Aegis remains bullish</a></h4><ul>\n<li>Trovagene (<a href=\"https://seekingalpha.com/symbol/TROV\" title=\"TrovaGene, Inc.\">TROV</a> <font color=\"green\">+13.1%</font>) is up double-digits after briefly trading in negative territory to start the day.</li>\n<li>The company reported a Q3 loss that was <a href=\"https://seekingalpha.com/currents/post/1414442\" target=\"_blank\">wider-than-expected</a> Thursday evening, but that's not enough to make Aegis lose faith.</li>\n<li>\"Although the firm's revenues were in-line with our modest estimates, the  [wider] loss per share ... was driven  primarily by higher-than-projected G&amp;A spending [and the] negative impact of $1.3M from the change in fair  value of warrants,\" analyst Raghuram Selvaraju says, before reiterating \"revenue projections of $500K in 2013 and $4.6M in 2014.\"</li>\n<li>Buy rating <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/11/4084552/aegis-capital-reiterates-on-trovagene-following-in-line-\" target=\"_blank\">maintained</a>.</li>\n<li>Price target is $10.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1416822\" data-linked=\"Trovagene manages rally after Q3 results; Aegis remains bullish\" data-tweet=\"$TROV - Trovagene manages rally after Q3 results; Aegis remains bullish https://seekingalpha.com/news/1416822-trovagene-manages-rally-after-q3-results-aegis-remains-bullish?source=tweet\" data-url=\"https://seekingalpha.com/news/1416822-trovagene-manages-rally-after-q3-results-aegis-remains-bullish\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1416752\" data-ts=\"1384545069\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVIV\" target=\"_blank\">NVIV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1416752-invivo-ligand-biostar-extend-gains-in-afternoon-trading\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">InVivo, Ligand, Biostar extend gains in afternoon trading</a></h4><ul>\n<li>Several of today's healthcare winners are extending their gains meaningfully as the sessions wears on.</li>\n<li>InVivo (<a href=\"https://seekingalpha.com/symbol/NVIV\" title=\"InVivo Therapeutics Holdings Corp\">NVIV</a> <font color=\"green\">+56%</font>) has skyrocketed since <a href=\"https://seekingalpha.com/currents/post/1416262\" target=\"_blank\">updating investors</a> on its degradable polymer scaffold program earlier in the day.</li>\n<li>Ligand Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/LGND\" title=\"Ligand Pharmaceuticals Incorporated\">LGND</a> <font color=\"green\">+8.5%</font>) has more than doubled its early gains on the strength of <a href=\"http://www.streetinsider.com/Upgrades/Cantor+Fitzgerald+Upgrades+Ligand+Pharma+%28LGND%29+to+Hold/8892872.html\" target=\"_blank\">an upgrade</a> at Cantor, where analyst Irina Rivkind is now \"more comfortable with the growth prospects for the business  based primarily on management's higher guidance on material sales and  milestones.\"</li>\n<li>Biostar Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/BSPM\" title=\"Biostar Pharmaceutic\">OTC:BSPM</a> <font color=\"green\">+16.5%</font>) is up double-digits after <a href=\"https://seekingalpha.com/currents/post/1415632\" target=\"_blank\">posting modest premarket gains</a>, bringing the two-day rally to <strong><font color=\"green\">~92%.</font></strong>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1416752\" data-linked=\"InVivo, Ligand, Biostar extend gains in afternoon trading\" data-tweet=\"$NVIV $NVIV $LGND - InVivo, Ligand, Biostar extend gains in afternoon trading https://seekingalpha.com/news/1416752-invivo-ligand-biostar-extend-gains-in-afternoon-trading?source=tweet\" data-url=\"https://seekingalpha.com/news/1416752-invivo-ligand-biostar-extend-gains-in-afternoon-trading\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1416732\" data-ts=\"1384543374\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XOM\" target=\"_blank\">XOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1416732-analysts-buffett-likes-exxon-but-that-doesnt-mean-everyone-should\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts: Buffett likes Exxon, but that doesn&#39;t mean everyone should</a></h4><ul>     <li>\u201cWhen Warren Buffett gives his <a href=\"http://www.reuters.com/article/2013/11/15/us-berkshire-buffett-holdings-idUSBRE9AD1BO20131115\" target=\"_blank\">seal of approval</a> to any company, that is never a bad thing,\u201d so Exxon Mobil (<a href=\"https://seekingalpha.com/symbol/XOM\" title=\"Exxon Mobil Corporation\">XOM</a> <font color=\"green\">+1.8%</font>) powers within reach of its 52-week high after Berkshire Hathaway <a href=\"https://seekingalpha.com/currents/post/1414692\" target=\"_blank\">added a 40M-share position</a>.</li>     <li>But Buffett's style of value investing may not work so well for the rest of us, even for those looking for a big defensive energy stock; Brian Youngberg of Edward Jones <a href=\"http://blogs.marketwatch.com/energy-ticker/2013/11/15/what-did-warren-buffet-see-in-exxon-and-should-you-follow-him/\" target=\"_blank\">prefers</a> Chevron (<a href=\"https://seekingalpha.com/symbol/CVX\" title=\"Chevron Corporation\">CVX</a> <font color=\"green\">+0.2%</font>), which he says is more attractively priced relative to XOM, offers a higher dividend yield, is more profitable per barrel, and has better potential for production volume growth.</li>     <li>Buffett's <a href=\"https://seekingalpha.com/article/1842172-dont-follow-buffett-into-exxon\" target=\"_blank\">underpinning thesis</a> for XOM purchase looks similar to his <a href=\"https://seekingalpha.com/currents/post/100940\" target=\"_blank\">2011 IBM purchase</a> - difficulty growing revenues but returning a significant amount of cash to shareholders - but investors who blindly followed Buffett into Big Blue in 2011 have significantly <a href=\"http://www.riskreversal.com/2013/11/15/morning-word-xom-buffett-buysbut-likely-a-much-better-price/\" target=\"_blank\">underperformed</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1416732\" data-linked=\"Analysts: Buffett likes Exxon, but that doesn&#39;t mean everyone should\" data-tweet=\"$XOM $XOM $CVX - Analysts: Buffett likes Exxon, but that doesn&#39;t mean everyone should https://seekingalpha.com/news/1416732-analysts-buffett-likes-exxon-but-that-doesnt-mean-everyone-should?source=tweet\" data-url=\"https://seekingalpha.com/news/1416732-analysts-buffett-likes-exxon-but-that-doesnt-mean-everyone-should\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1416712\" data-ts=\"1384543207\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTWO\" target=\"_blank\">TTWO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1416712-ea-gamestop-slip-after-npd-releases-oct-game-figures\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EA, GameStop slip after NPD releases Oct. game figures</a></h4><ul><li>After rising 52% Y/Y <a href=\"https://seekingalpha.com/currents/post/1337992\" target=\"_blank\">in September</a> on the back of huge sales for Take-Two's (<a href='https://seekingalpha.com/symbol/TTWO' title='Take-Two Interactive Software, Inc.'>TTWO</a> <font color='red'>-0.2%</font>) <em>Grand Theft Auto V</em>, NPD estimates U.S. physical retail video game sales <a href=\"http://venturebeat.com/2013/11/14/october-2013-npd-pokemon-powers-3ds-to-sixth-straight-month-at-top/\" target=\"_blank\">only rose 12% Y/Y</a> in October ahead of this month's PlayStation 4 (launching today) and Xbox One (launching on Nov. 22) debuts. <em>GTA V</em> was once more the bestselling title.</li><li>GameStop (<a href='https://seekingalpha.com/symbol/GME' title='GameStop Corp.'>GME</a> <font color='red'>-2.2%</font>) is selling off on the wake of NPD's numbers, and so is Electronic Arts (<a href='https://seekingalpha.com/symbol/EA' title='Electronic Arts Inc.'>EA</a> <font color='red'>-5.7%</font>). Investors in the latter might not be pleased <em>Madden NFL 25</em> (#2 in September and #1 in August) and <em>FIFA 14</em> (#5 in September) fell out of the&nbsp;NPD's list of the ten top-selling games. EA's <em>Battlefield 4</em>, which <a href=\"https://seekingalpha.com/currents/post/1365312\" target=\"_blank\">launched </a>near the end of the month to muted reviews, came in at #4.</li><li>Take-Two's <em>NBA 2K14</em> (#3 in September) and <em>WWE 2K14</em> respectively came in at #7 and #10.</li><li>Activision's (<a href='https://seekingalpha.com/symbol/ATVI' title='Activision Blizzard, Inc'>ATVI</a> - unchanged)&nbsp;<em>Skylanders: Swap Force</em> was #8 on the list. <em>Diablo III</em>, which was #4 in September, dropped out of the top-10.</li><li>Hardware sales fell 8% ahead of the PS4/Xbox One launches, and only totaled $171.7M. Accessories sales rose 1%.</li></ul><div class=\"tiny-share-widget\" data-id=\"1416712\" data-linked=\"EA, GameStop slip after NPD releases Oct. game figures\" data-tweet=\"$TTWO $TTWO $GME - EA, GameStop slip after NPD releases Oct. game figures https://seekingalpha.com/news/1416712-ea-gamestop-slip-after-npd-releases-oct-game-figures?source=tweet\" data-url=\"https://seekingalpha.com/news/1416712-ea-gamestop-slip-after-npd-releases-oct-game-figures\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:20 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1416562\" data-ts=\"1384537820\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BMRN\" target=\"_blank\">BMRN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1416562-fda-says-biomarin-drug-results-in-modest-improvements\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA says BioMarin drug results in &quot;modest&quot; improvements</a></h4><ul><li>BioMarin (<a href='https://seekingalpha.com/symbol/BMRN' title='BioMarin Pharmaceutical Inc.'>BMRN</a> <font color='green'>+8.3%</font>) has put together a strong session after starting the day only slightly higher.</li><li>Available now are the briefing docs for next week's <a href=\"https://seekingalpha.com/currents/search?query=Vimizim\" target=\"_blank\">Vimizim</a> Ad Com.<br></li><li>FDA staff characterizes the benefit conferred on Morquio A patients as \"modest.\"</li><li><a href=\"http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM375126.pdf\" target=\"_blank\">Full documents</a></li></ul><div class=\"tiny-share-widget\" data-id=\"1416562\" data-linked=\"FDA says BioMarin drug results in &quot;modest&quot; improvements\" data-tweet=\"$BMRN - FDA says BioMarin drug results in &quot;modest&quot; improvements https://seekingalpha.com/news/1416562-fda-says-biomarin-drug-results-in-modest-improvements?source=tweet\" data-url=\"https://seekingalpha.com/news/1416562-fda-says-biomarin-drug-results-in-modest-improvements\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1416552\" data-ts=\"1384537536\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1416552-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Top 10 Gainers:</b> <a href='https://seekingalpha.com/symbol/ICLD-OLD' title='InterCloud Systems, Inc.'>ICLD</a> <font color='green'>+202%</font>. <a href='https://seekingalpha.com/symbol/FONR' title='Fonar Corporation'>FONR</a> <font color='green'>+43%</font>. <a href='https://seekingalpha.com/symbol/BSPM' title='Biostar Pharmaceutic'>OTC:BSPM</a> <font color='green'>+39%</font>. CADX <font color='green'>+36%</font>. <a href='https://seekingalpha.com/symbol/AMCF' title='Andatee China Marine Fuel Services Corporation'>OTC:AMCF</a> <font color='green'>+30%</font>. <a href='https://seekingalpha.com/symbol/SYUT' title='Synutra International, Inc.'>SYUT</a> <font color='green'>+33%</font>. <a href='https://seekingalpha.com/symbol/VISN' title='VisionChina Media, Inc.'>VISN</a> <font color='green'>+25%</font>. DXM <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/FMI' title='Foundation Medicine, Inc.'>FMI</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/INOC' title='Innotrac Corporation'>INOC</a> <font color='green'>+19%</font>.</li><li><b>Top 10 Losers:</b> <a href='https://seekingalpha.com/symbol/SUMR' title='Summer Infant, Inc.'>SUMR</a> <font color='red'>-22%</font>. AFFM <font color='red'>-21%</font>. CRDC <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/CRMB' title='Crumbs Bake Shop, Inc'>CRMB</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/ZOOM' title='Zoom Technologies, Inc.'>ZOOM</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/SANW' title='S&W Seed Co'>SANW</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/GSE' title='GSE Holding'>GSE</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/CET' title='Central Securities'>CET</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/RMGN' title='RMG Networks'>RMGN</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/CREG' title='China Recycling Energy Corporation'>CREG</a> <font color='red'>-12%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1416552\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$ICLD-OLD $FONR $BSPM - Midday Gainers / Losers https://seekingalpha.com/news/1416552-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1416552-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1416472\" data-ts=\"1384536677\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKRX\" target=\"_blank\">AKRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1416472-akorn-acquires-eye-drop-solutions-from-merck-in-52_8m-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Akorn acquires eye drop solutions from Merck in $52.8M deal</a></h4><ul>\n<li>Niche generic maker Akorn (<a href=\"https://seekingalpha.com/symbol/AKRX\" title=\"Akorn, Inc.\">AKRX</a> <font color=\"green\">+4.5%</font>) rises after announcing the acquisition of the U.S. rights to AzaSite, COSOPT, COSOPT PF (they're all eye drop solutions) from Merck (<a href=\"https://seekingalpha.com/symbol/MRK\" title=\"Merck &amp; Co Inc.\">MRK</a> <font color=\"green\">+0.3%</font>) for $52.8M.</li>\n<li>The move \"further expands [our] position as a leader in U.S. ophthalmology products,\" AKRX CEO Raj       Rai says.</li>\n<li>For MRK, the deal is consistent with its \"ongoing strategy to sharpen commercial focus and       improve operational effectiveness.\" (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1416472\" data-linked=\"Akorn acquires eye drop solutions from Merck in $52.8M deal\" data-tweet=\"$AKRX $AKRX $MRK - Akorn acquires eye drop solutions from Merck in $52.8M deal https://seekingalpha.com/news/1416472-akorn-acquires-eye-drop-solutions-from-merck-in-52_8m-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/1416472-akorn-acquires-eye-drop-solutions-from-merck-in-52_8m-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:31 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1416452\" data-ts=\"1384536160\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EMES\" target=\"_blank\">EMES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1416452-emerge-energy-pushes-higher-after-stifel-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Emerge Energy pushes higher after Stifel upgrade</a></h4><ul>     <li>Emerge Energy Services (<a href=\"https://seekingalpha.com/symbol/EMES\" title=\"Emerge Energy Services LP\">EMES</a> <font color=\"green\">+3.3%</font>) is <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/11/4084251/update-stifel-upgrades-emerge-energy-services-on-expecte\" target=\"_blank\">upgraded to Buy</a> from Hold with a $44 target price at Stifel, which continues to believe sand operations will be the growth driver for  EMEs through FY 2014 as it focuses on filling the capacity at its Barron facility.</li>     <li>During the  quarter, the firm estimates production grew ~55K tons to 344K tons at Barron facility, and pricing should remain firm for at least the next year as the partnership benefits from high demand for its sand.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1416452\" data-linked=\"Emerge Energy pushes higher after Stifel upgrade\" data-tweet=\"$EMES - Emerge Energy pushes higher after Stifel upgrade https://seekingalpha.com/news/1416452-emerge-energy-pushes-higher-after-stifel-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/1416452-emerge-energy-pushes-higher-after-stifel-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:22 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1416432\" data-ts=\"1384535235\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MLNX\" target=\"_blank\">MLNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1416432-mellanox-soars-on-news-of-big-insider-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mellanox soars on news of big insider buy</a></h4><ul>\n<li>Mellanox (<a href=\"https://seekingalpha.com/symbol/MLNX\" title=\"Mellanox Technologies, Ltd.\">MLNX</a> <font color=\"green\">+11.1%</font>) director Dov Baharav discloses he <a href=\"http://www.insidermonkey.com/insider-trading/filing/4182941\" target=\"_blank\">bought 57.7K shares</a> on Tuesday at a price of $34.64.</li>\n<li>The maker of InfiniBand and high-speed Ethernet switches and adapter cards remains down 34% YTD, and 67% from its Aug. '12 highs. Shares have been pressured this year by <a href=\"https://seekingalpha.com/currents/post/1249622\" target=\"_blank\">server industry weakness</a>, slowing growth for top customer Oracle's engineered systems, and concerns about <a href=\"https://seekingalpha.com/currents/post/1151262\" target=\"_blank\">Intel's plans</a> to launch server CPUs in 2014 that feature built-in I/O connectivity.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1416432\" data-linked=\"Mellanox soars on news of big insider buy\" data-tweet=\"$MLNX - Mellanox soars on news of big insider buy https://seekingalpha.com/news/1416432-mellanox-soars-on-news-of-big-insider-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/1416432-mellanox-soars-on-news-of-big-insider-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1416372\" data-ts=\"1384534574\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/P\" target=\"_blank\">P</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1416372-pandora-surges-following-jpmorgan-note-hedge-fund-disclosures\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pandora surges following JPMorgan note, hedge fund disclosures</a></h4><ul><li>Three days after <a href=\"https://seekingalpha.com/currents/post/1407692\" target=\"_blank\">Needham issued</a> a bullish note on Pandora (<a href='https://seekingalpha.com/symbol/P' title='Pandora Media'>P</a> <font color='green'>+6.2%</font>) ahead of its Nov. 21 FQ3 report, JPMorgan is joining in. The firm has raised its PT to $35 from $25, while declaring the Internet radio leader is nearing a revenue \"inflection point\" thanks to share gains and salesforce investments.</li><li>Also helping Pandora: Hedge funds Coatue Management and Tiger Consumer Management (both offshoots of Julian Robertson's Tiger Management) <a href=\"http://finance.yahoo.com/news/hedge-funds-tune-pandora-discard-010953004.html\" target=\"_blank\">have disclosed</a> they respectively opened 1.1M and 2.9-share positions in Pandora in Q3. Between them, Coatue and Tiger Consumer owned over 2% of the company at quarter's end.</li><li>Stephen Mandel's Lone Pine Capital owned 10.1M Pandora shares at the end of Q3, unchanged from when Lone Pine <a href=\"https://seekingalpha.com/currents/post/1313342\" target=\"_blank\">originally disclosed</a> a position in the company on Oct. 3. (<a href=\"http://www.sec.gov/Archives/edgar/data/1061165/000090266413003750/xslForm13F_X01/infotable.xml\" target=\"_blank\">13F</a>)</li></ul><div class=\"tiny-share-widget\" data-id=\"1416372\" data-linked=\"Pandora surges following JPMorgan note, hedge fund disclosures\" data-tweet=\"$P - Pandora surges following JPMorgan note, hedge fund disclosures https://seekingalpha.com/news/1416372-pandora-surges-following-jpmorgan-note-hedge-fund-disclosures?source=tweet\" data-url=\"https://seekingalpha.com/news/1416372-pandora-surges-following-jpmorgan-note-hedge-fund-disclosures\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1416332\" data-ts=\"1384534196\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RLYP\" target=\"_blank\">RLYP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1416332-relypsa-up-in-debut-but-off-highs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Relypsa up in debut, but off highs</a></h4><ul>\n<li>Relypsa (<a href=\"https://seekingalpha.com/symbol/RLYP\" title=\"Relypsa, Inc.\">RLYP</a> <font color=\"green\">+8.5%</font>) opens at $12.47, or around <font color=\"green\">13%</font> above where the IPO <a href=\"http://www.nasdaq.com/article/relypsa-prices-ipo-at-11-below-expectations-cm301485\" target=\"_blank\">priced</a>.</li>\n<li>The company is developing patiromer for the treatment of hyperkalemia.</li>\n<li>Earlier this month, RLYP <a href=\"http://www.relypsa.com/news/2013/2013.11.09.html\" target=\"_blank\">reported more data to support</a> significant top-line efficacy results from a two-part clinical trial.</li>\n<li>The company notes that it has  \"global royalty-free  commercialization rights to patiromer, which has  intellectual property  protection in the U.S. until at least 2030.\"</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1416332\" data-linked=\"Relypsa up in debut, but off highs\" data-tweet=\"$RLYP - Relypsa up in debut, but off highs https://seekingalpha.com/news/1416332-relypsa-up-in-debut-but-off-highs?source=tweet\" data-url=\"https://seekingalpha.com/news/1416332-relypsa-up-in-debut-but-off-highs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1416322\" data-ts=\"1384533611\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GEVO\" target=\"_blank\">GEVO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1416322-ford-coca-cola-teaming-up-to-use-gevos-plantbottle-technology\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ford, Coca-Cola teaming up to use Gevo&#39;s PlantBottle technology</a></h4><ul>     <li>Gevo's (<a href='https://seekingalpha.com/symbol/GEVO' title='Gevo, Inc.'>GEVO</a> <font color='green'>+10.1%</font>) strong gains are sparked by news that Ford (NYSE:<a href='https://seekingalpha.com/symbol/F' title='Ford Motor Company'>F</a>) and Coca-Cola (NYSE:<a href='https://seekingalpha.com/symbol/KO' title='The Coca-Cola Company'>KO</a>) plan to turn bottles into car parts using Gevo's <a href=\"http://ir.gevo.com/phoenix.zhtml?c=238618&amp;p=irol-newsArticle&amp;ID=1640177&amp;highlight=\" target=\"_blank\">PlantBottle technology</a>, which is made up of 30% plant-based materials.</li><li>Ford's Fusion Energi plug-in hybrid  vehicle <a href=\"http://finance.yahoo.com/news/driving-innovation-coca-cola-company-050100434.html\" target=\"_blank\">will use PlantBottle interior fabric surfaces</a>  covering seat cushions, seat backs, head restraints, door panel inserts  and headliners; the research vehicle marks the first time PlantBottle technology is applied beyond packaging.</li>     <li>PlantBottle essentially uses ethanol derived  from sugar cane to create a modified PET which replaces regular petroleum-based PET.</li></ul><div class=\"tiny-share-widget\" data-id=\"1416322\" data-linked=\"Ford, Coca-Cola teaming up to use Gevo&#39;s PlantBottle technology\" data-tweet=\"$GEVO $GEVO $F - Ford, Coca-Cola teaming up to use Gevo&#39;s PlantBottle technology https://seekingalpha.com/news/1416322-ford-coca-cola-teaming-up-to-use-gevos-plantbottle-technology?source=tweet\" data-url=\"https://seekingalpha.com/news/1416322-ford-coca-cola-teaming-up-to-use-gevos-plantbottle-technology\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1416302\" data-ts=\"1384533129\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZU\" target=\"_blank\">ZU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1416302-zulilys-ipo-skyrockets\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zulily&#39;s IPO skyrockets</a></h4><ul>\n<li>After <a href=\"https://seekingalpha.com/currents/post/1415242\" target=\"_blank\">pricing</a> its 11.5M-share IPO at $22, Zulily (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ZU\" title=\"Zulily, Inc.\">ZU</a>) opened at $39 and is now at $40.01, <strong><font color=\"green\">up 81.9%</font></strong>. That gives the apparel flash deals site a market cap of $4.88B, or 7x-8x its likely 2013 sales.</li>\n<li>\n<a href=\"https://seekingalpha.com/mafne.html?source=market_currents&amp;anew_id=1415242&amp;url=http%3A//www.sec.gov/Archives/edgar/data/1478484/000119312513439207/d552850ds1a.htm\" target=\"_blank\">S-1</a>, <a href=\"https://seekingalpha.com/article/1842232-ipo-preview-zulily\" target=\"_blank\">IPO preview</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1416302\" data-linked=\"Zulily&#39;s IPO skyrockets\" data-tweet=\"$ZU - Zulily&#39;s IPO skyrockets https://seekingalpha.com/news/1416302-zulilys-ipo-skyrockets?source=tweet\" data-url=\"https://seekingalpha.com/news/1416302-zulilys-ipo-skyrockets\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:32 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1416292\" data-ts=\"1384532803\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STP\" target=\"_blank\">STP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1416292-suntechs-liquidators-object-to-wuxi-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Suntech&#39;s liquidators object to Wuxi sale</a></h4><ul>\n<li>Suntech's (NYSE:<a href=\"https://seekingalpha.com/symbol/STP\" title=\"Suntech Power Holdings Co., Ltd.\">STP</a>) court-appointed Cayman Islands liquidators <a href=\"http://www.ft.com/intl/cms/s/0/7e14459c-4dbd-11e3-8fa5-00144feabdc0.html#axzz2kiYEK8gI\" target=\"_blank\">have objected</a> to the <a href=\"https://seekingalpha.com/currents/post/1381062\" target=\"_blank\">$492M sale</a> of the company's massive Wuxi, China unit to solar cell manufacturer Shunfeng.</li>\n<li>It's unclear if the liquidators will be able to stop the sale. An officer at the Wuxi Intermediate Court states the deal is \"already settled.\"</li>\n<li>Suntech shares initially dove on the pink sheets in response to the news, but are now close to breakeven. They <a href=\"https://seekingalpha.com/currents/post/1413792\" target=\"_blank\">rallied yesterday</a>, but are still down sharply from where they traded before the company announced on Nov. 6 it had filed for a \"<a href=\"https://seekingalpha.com/currents/post/1391172\" target=\"_blank\">provisional liquidation</a>\" in the Cayman Islands.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1416292\" data-linked=\"Suntech&#39;s liquidators object to Wuxi sale\" data-tweet=\"$STP - Suntech&#39;s liquidators object to Wuxi sale https://seekingalpha.com/news/1416292-suntechs-liquidators-object-to-wuxi-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/1416292-suntechs-liquidators-object-to-wuxi-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1416252\" data-ts=\"1384531867\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DANG\" target=\"_blank\">DANG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1416252-dangdang-adds-to-post-earnings-gains-following-hsbc-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dangdang adds to post-earnings gains following HSBC upgrade</a></h4><ul>     <li>HSBC has upgraded Dangdang (<a href=\"https://seekingalpha.com/symbol/DANG\" title=\"E-Commerce China Dangdang Inc.\">DANG</a> <font color=\"green\">+4.3%</font>) to Overweight, and set a PT of $12 (23% above current levels).<a href=\"https://seekingalpha.com/currents/post/1412002\" target=\"_blank\"><br>     </a>\n</li>     <li>The Chinese e-commerce firm rallied yesterday after providing <a href=\"https://seekingalpha.com/currents/post/1412002\" target=\"_blank\">mixed Q3 results</a> and below-consensus <a href=\"https://seekingalpha.com/currents/post/1413152\" target=\"_blank\">Q4 revenue guidance</a>, as investors focused on the company's improving margins rather than its slowing top-line growth.</li>     <li>Shares <strong><font color=\"green\">+135%</font></strong> YTD.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1416252\" data-linked=\"Dangdang adds to post-earnings gains following HSBC upgrade\" data-tweet=\"$DANG - Dangdang adds to post-earnings gains following HSBC upgrade https://seekingalpha.com/news/1416252-dangdang-adds-to-post-earnings-gains-following-hsbc-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/1416252-dangdang-adds-to-post-earnings-gains-following-hsbc-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1416182\" data-ts=\"1384531029\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZU\" target=\"_blank\">ZU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1416182-zulily-indicated-to-open-at-36\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zulily indicated to open at $36</a></h4><ul>\n<li>Zulily's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ZU\" title=\"Zulily, Inc.\">ZU</a>) indicated opening price is 64% above its IPO price of $22, and would give the company a valuation of $4.4B.</li>\n<li>\n<strong>Update (11:18AM ET):</strong> Shares are now indicated to open in the $38-$39 range.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1416182\" data-linked=\"Zulily indicated to open at $36\" data-tweet=\"$ZU - Zulily indicated to open at $36 https://seekingalpha.com/news/1416182-zulily-indicated-to-open-at-36?source=tweet\" data-url=\"https://seekingalpha.com/news/1416182-zulily-indicated-to-open-at-36\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1416152\" data-ts=\"1384530766\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDRX\" target=\"_blank\">MDRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1416152-allscripts-jumps-following-leerink-swann-upgrade-survey-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Allscripts jumps following Leerink Swann upgrade, survey data</a></h4><ul><li>Leerink Swann's <a href=\"http://www.streetinsider.com/Analyst+Comments/Leerink+Swann+Raises+Allscripts+%28MDRX%29+to+Outperform+Following+PHM+Survey+and+Analysis/8892917.html\" target=\"_blank\">David Larsen</a> has upgraded Allscripts (<a href='https://seekingalpha.com/symbol/MDRX' title='Allscripts Healthcare Solutions, Inc.'>MDRX</a> <font color='green'>+7%</font>) to Outperform, and lifted his PT to $18 from $16. He notes a recent health management survey indicated only 5%-15% of the hospital industry's revenue is \"currently tied to an ACO, risk, or clinical outcomes [models],\" and that this could rise to 30%-40% over the next five years.</li><li>The survey also points to \"rising demand for patient portals, mobile apps, clinical analytics, discharge solutions and home-health monitoring,\" all of which would benefit Allscripts.</li><li>Larsen's upgrade comes a week after Allscripts posted a <a href=\"https://seekingalpha.com/currents/post/1397512\" target=\"_blank\">Q3 miss</a>. Shares are <font color='green'>up 60%</font> YTD.</li></ul><div class=\"tiny-share-widget\" data-id=\"1416152\" data-linked=\"Allscripts jumps following Leerink Swann upgrade, survey data\" data-tweet=\"$MDRX - Allscripts jumps following Leerink Swann upgrade, survey data https://seekingalpha.com/news/1416152-allscripts-jumps-following-leerink-swann-upgrade-survey-data?source=tweet\" data-url=\"https://seekingalpha.com/news/1416152-allscripts-jumps-following-leerink-swann-upgrade-survey-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1416092\" data-ts=\"1384529868\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MSFT\" target=\"_blank\">MSFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1416092-linkedin-rallies-after-stifel-assigns-buy-rating-300-pt\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LinkedIn rallies after Stifel assigns Buy rating, $300 PT</a></h4><ul>\n<li>Stifel's LinkedIn (LNKD <font color=\"green\">+4.6%</font>) PT represents a 29% premium to where shares currently trade, and a 161% premium to where they traded to start the year. It also equals a valuation of $33.6B, or 135x consensus 2014 EPS.</li>\n<li>Analyst <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/11/4084232/update-stifel-initiates-coverage-on-linkedin-on-pivotal-\" target=\"_blank\">Michael Purcell</a> gushes with praise for the professional social network, declaring it's \"evolving into a critical daily or weekly platform for professional workers of all types,\" and will \"remain pivotal in the increasingly complex forces of global business expansion and labor.\"</li>\n<li>Sell-side commentary on LinkedIn has been quite bullish lately. ITG Research recently reported LinkedIn's Q4 was tracking above consensus, and <a href=\"http://www.streetinsider.com/Analyst+Comments/LinkedIn+%28LNKD%29+is+Just+Scratching+the+Surface+of+Growth+-+Needham+%26+Company/8887518.html\" target=\"_blank\">Needham</a> has reiterated a Buy and $280 PT following an upbeat investor meeting with CFO Steve Sordello.</li>\n<li>Among other things, Needham is upbeat about LinkedIn's <a href=\"http://www.linkedin.com/company/linkedin/linkedin-sales-navigator-899344/product\" target=\"_blank\">Sales Navigator</a> social selling tool (just beginning to ramp), and notes management sees many HR opportunities, including training and performance management.</li>\n<li>Needham: \"The holy grail is to recruit, train and measure the effectiveness of employees all through one platform.\" Such an offering could put LinkedIn into competition with a variety of cloud HR software firms, such as Workday, Ultimate Software, and Cornerstone OnDemand.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1416092\" data-linked=\"LinkedIn rallies after Stifel assigns Buy rating, $300 PT\" data-tweet=\"$MSFT - LinkedIn rallies after Stifel assigns Buy rating, $300 PT https://seekingalpha.com/news/1416092-linkedin-rallies-after-stifel-assigns-buy-rating-300-pt?source=tweet\" data-url=\"https://seekingalpha.com/news/1416092-linkedin-rallies-after-stifel-assigns-buy-rating-300-pt\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1416052\" data-ts=\"1384529410\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OTIV\" target=\"_blank\">OTIV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1416052-on-track-innovations-continues-to-climb-sa-pro-article-sees-possibility-of-5x-return\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">On Track Innovations continues to climb, SA Pro article sees possibility of 5x return</a></h4><ul>\n<li>On Track Innovations (<a href=\"https://seekingalpha.com/symbol/OTIV\" title=\"On Track Innovations Ltd\">OTIV</a> <font color=\"green\">+6.8%</font>) shares trade up, possibly on an <a href=\"https://seekingalpha.com/article/1842482-on-track-innovations-improving-ops-and-valuable-ip-is-formula-for-multi-bagger?source=email_rt_pro_article_title&amp;app=p\" target=\"_blank\">SA Pro piece</a> by Valuable Insights (embargoed until 9:30 am ET tomorrow) that claims OTIV has a \"realistic chance of delivering a 5x or better return over the next 12 months.\"</li>\n<li>Valuable Insights believes the company is on the \"cusp of a significant operational turnaround,\" having shed non-core assets, secured new contracts, and built tech that will fuel revenue growth in 2014.</li>\n<li>A valuation gap exists between OTIV's fundamentals and its misunderstood, under-covered equity, the author concludes.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1416052\" data-linked=\"On Track Innovations continues to climb, SA Pro article sees possibility of 5x return\" data-tweet=\"$OTIV - On Track Innovations continues to climb, SA Pro article sees possibility of 5x return https://seekingalpha.com/news/1416052-on-track-innovations-continues-to-climb-sa-pro-article-sees-possibility-of-5x-return?source=tweet\" data-url=\"https://seekingalpha.com/news/1416052-on-track-innovations-continues-to-climb-sa-pro-article-sees-possibility-of-5x-return\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1416022\" data-ts=\"1384528538\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTIC\" target=\"_blank\">CTIC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1416022-cell-therapeutics-rallies-on-pacritinib-partnership\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cell Therapeutics rallies on pacritinib partnership</a></h4><ul>\n<li>Cell Therapeutics (<a href=\"https://seekingalpha.com/symbol/CTIC\" title=\"CTI BioPharma Corp.\">CTIC</a> <font color=\"green\">+20.6%</font>) soars as investors react to news the company has inked a licensing agreement with Baxter (<a href=\"https://seekingalpha.com/symbol/BAX\" title=\"Baxter International Inc\">BAX</a> <font color=\"green\">+0.9%</font>) for the development and commercialization of <a href=\"https://seekingalpha.com/currents/search?query=pacritinib\" target=\"_blank\">pacritinib.</a> </li>\n<li>As for Incyte (<a href=\"https://seekingalpha.com/symbol/INCY\" title=\"Incyte Corporation\">INCY</a> <font color=\"green\">+2.6%</font>) \u2014 whose <a href=\"https://seekingalpha.com/currents/search?query=jakafi\" target=\"_blank\">Jakafi</a> also treats myelofibrosis \u2014 any downside the shares might have realized from the prospective competition appears to be taking a backseat to either a <a href=\"http://www.sec.gov/Archives/edgar/data/879169/000114420413062120/v360498_sc13da.htm\" target=\"_blank\">13D</a> filing by Baker Bros. or perhaps a <a href=\"https://twitter.com/ChillzTrading/status/401341554326896641\" target=\"_blank\">price target hike</a> at Brean.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1416022\" data-linked=\"Cell Therapeutics rallies on pacritinib partnership\" data-tweet=\"$CTIC $CTIC $BAX - Cell Therapeutics rallies on pacritinib partnership https://seekingalpha.com/news/1416022-cell-therapeutics-rallies-on-pacritinib-partnership?source=tweet\" data-url=\"https://seekingalpha.com/news/1416022-cell-therapeutics-rallies-on-pacritinib-partnership\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1416002\" data-ts=\"1384528383\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RGSE\" target=\"_blank\">RGSE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1416002-real-goods-solar-lower-after-pricing-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Real Goods Solar lower after pricing stock offering</a></h4><ul>\n<li>Real Goods Solar (RSOL <font color=\"red\">-4.7%</font>) is selling 5.9M shares at $3.40, even with yesterday's closing price. Gross proceeds are set to total $20M, and net proceeds $18.4M. (PR)</li>\n<li>RSOL says its will use the proceeds for \"general corporate purposes including investments in greater sales and project origination capabilities and potential use of funds for appropriate acquisitions.\"</li>\n<li>The offering stands to increase RSOL's diluted share count by nearly 20%.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1416002\" data-linked=\"Real Goods Solar lower after pricing stock offering\" data-tweet=\"$RGSE - Real Goods Solar lower after pricing stock offering https://seekingalpha.com/news/1416002-real-goods-solar-lower-after-pricing-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/1416002-real-goods-solar-lower-after-pricing-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1415982\" data-ts=\"1384527856\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GMCR\" target=\"_blank\">GMCR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1415982-positive-channel-checks-on-green-mountain-coffee-roasters-from-keybanc\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Positive channel checks on Green Mountain Coffee Roasters from KeyBanc</a></h4><ul>     <li>KeyBanc is out with a <a href=\"https://twitter.com/thenotablecalls/status/401360535456731136\" target=\"_blank\">new defense</a> of Green Mountain Coffee Roasters (<a href=\"https://seekingalpha.com/symbol/GMCR\" title=\"Keurig Green Mountain Inc\">GMCR</a> <font color=\"green\">+1.9%</font>) as it keeps a Buy rating and $100 price target on the company locked in place.</li>     <li>The investment firm doesn't think GMCR will lose market share or suffer through a pricing war as some skeptics have forecast based on what its recent channel checks have shown.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"1415982\" data-linked=\"Positive channel checks on Green Mountain Coffee Roasters from KeyBanc\" data-tweet=\"$GMCR - Positive channel checks on Green Mountain Coffee Roasters from KeyBanc https://seekingalpha.com/news/1415982-positive-channel-checks-on-green-mountain-coffee-roasters-from-keybanc?source=tweet\" data-url=\"https://seekingalpha.com/news/1415982-positive-channel-checks-on-green-mountain-coffee-roasters-from-keybanc\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:04 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1415912\" data-ts=\"1384526814\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AZN\" target=\"_blank\">AZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1415912-healthcare-upgrades-and-initiations-for-friday\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare upgrades and initiations for Friday</a></h4><ul>\n<li>AstraZeneca (<a href=\"https://seekingalpha.com/symbol/AZN\" title=\"AstraZeneca Group plc\">AZN</a> <font color=\"green\">+0.5%</font>) <a href=\"http://www.benzinga.com/analyst-ratings/upgrades/13/11/4083961/benzingas-top-upgrades\" target=\"_blank\">upgraded</a> to Buy at Liberum.</li>\n<li>Ligand Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/LGND\" title=\"Ligand Pharmaceuticals Incorporated\">LGND</a> <font color=\"green\">+4.4%</font>) <a href=\"http://www.streetinsider.com/news.php?id=8892872\" target=\"_blank\">upgraded</a> to Hold from Sell at Cantor.</li>\n<li>Vivus (<a href=\"https://seekingalpha.com/symbol/VVUS\" title=\"Vivus, Inc.\">VVUS</a> <font color=\"green\">+3.6%</font>) <a href=\"http://www.streetinsider.com/news.php?id=8892734\" target=\"_blank\">initiated</a> at Hold at WallachBeth.</li>\n<li>Synageva BioPharma (<a href=\"https://seekingalpha.com/symbol/GEVA\" title=\"Synageva BioPharma Corp.\">GEVA</a> <font color=\"green\">+5.9%</font>) <a href=\"http://www.streetinsider.com/news.php?id=8892777\" target=\"_blank\">initiated</a> at Buy at Goldman. Price target is $72 (upside of <font color=\"green\">37%</font> from Thursday's close).</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1415912\" data-linked=\"Healthcare upgrades and initiations for Friday\" data-tweet=\"$AZN $AZN $LGND - Healthcare upgrades and initiations for Friday https://seekingalpha.com/news/1415912-healthcare-upgrades-and-initiations-for-friday?source=tweet\" data-url=\"https://seekingalpha.com/news/1415912-healthcare-upgrades-and-initiations-for-friday\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1415902\" data-ts=\"1384526774\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TMUS\" target=\"_blank\">TMUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1415902-t-mobile-usa-prices-stock-offering-at-25-shares-drop\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">T-Mobile USA prices stock offering at $25, shares drop</a></h4><ul>\n<li>T-Mobile's (<a href=\"https://seekingalpha.com/symbol/TMUS\" title=\"T-Mobile US, Inc.\">TMUS</a> <font color=\"red\">-1.4%</font>) offering price is 2% below yesterday's close, and 7% below where shares traded when the offering was <a href=\"https://seekingalpha.com/currents/post/1404402\" target=\"_blank\">announced</a> on Monday. (PR)</li>\n<li>With T-Mobile selling 66.15M shares, gross proceeds are set to total $1.65B, and the carrier's share count is set to grow by 9%. Underwriters have a 6.615M-share overallotment option.</li>\n<li>\n<a href=\"https://seekingalpha.com/currents/post/1407652\" target=\"_blank\">T-Mobile has suggested</a> it might use the proceeds to buy spectrum from a private party.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1415902\" data-linked=\"T-Mobile USA prices stock offering at $25, shares drop\" data-tweet=\"$TMUS - T-Mobile USA prices stock offering at $25, shares drop https://seekingalpha.com/news/1415902-t-mobile-usa-prices-stock-offering-at-25-shares-drop?source=tweet\" data-url=\"https://seekingalpha.com/news/1415902-t-mobile-usa-prices-stock-offering-at-25-shares-drop\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1415842\" data-ts=\"1384525717\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMWD\" target=\"_blank\">AMWD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1415842-american-woodmark-to-join-s-and-p-smallcap-600\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Woodmark to join S&amp;P SmallCap 600</a></h4><ul><li>American Woodmark (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AMWD\" title=\"American Woodmark Corporation\">AMWD</a>) <font color=\"green\">+1.6%</font> premarket on last night's news that it <a href=\"https://www.spice-indices.com/idpfiles/spice-assets/resources/public/documents/63343_american6nash.pdf\" target=\"_blank\">will replace</a> Nash-Finch (NYSEMKT:<a href=\"https://seekingalpha.com/symbol/NFC-OLD\" title=\"Nuveen Connecticut Dividend Advantage Municipal Fund\">NFC-OLD</a>)  in the S&amp;P SmallCap 600 after the close of trading Nov. 19.</li></ul><div class=\"tiny-share-widget\" data-id=\"1415842\" data-linked=\"American Woodmark to join S&amp;P SmallCap 600\" data-tweet=\"$AMWD $AMWD $NFC-OLD - American Woodmark to join S&amp;P SmallCap 600 https://seekingalpha.com/news/1415842-american-woodmark-to-join-s-and-p-smallcap-600?source=tweet\" data-url=\"https://seekingalpha.com/news/1415842-american-woodmark-to-join-s-and-p-smallcap-600\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1415762\" data-ts=\"1384524458\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SAP\" target=\"_blank\">SAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1415762-a-roundup-of-tech-ratings-changes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">A roundup of tech ratings changes</a></h4><ul>     <li>\n<a href=\"https://seekingalpha.com/symbol/SAP\" title=\"SAP AG\">SAP</a> has been upgraded to Overweight by Barclays. Shares <font color=\"green\">+1.3%</font> premarket.</li>     <li>Ericsson (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ERIC\" title=\"LM Ericsson Telephone Company\">ERIC</a>) has been upgraded to Buy by Banco Santander. Shares <font color=\"green\">+2%</font>.</li>\n<li>Millennial Media (NYSE:<a href=\"https://seekingalpha.com/symbol/MM\" title=\"Millennial Media, Inc.\">MM</a>) has been cut to Neutral by Goldman two days after it posted a disappointing Q3 report (<a href=\"https://seekingalpha.com/currents/post/1411242\" target=\"_blank\">I</a>, <a href=\"https://seekingalpha.com/currents/post/1411512\" target=\"_blank\">III</a>).</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/GOGO\" title=\"Gogo\">GOGO</a> has been cut to Underweight by Morgan Stanley following a huge run-up in response to a <a href=\"https://seekingalpha.com/currents/post/1403062\" target=\"_blank\">strong Q3 report</a> and a positive <a href=\"https://seekingalpha.com/currents/post/1375112\" target=\"_blank\">FAA ruling</a>. Two other firms <a href=\"https://seekingalpha.com/currents/post/1407092\" target=\"_blank\">have already downgraded</a> the in-flight Wi-Fi provider since its Q3 report. Shares <font color=\"red\">-3.1%</font>.</li>\n<li>ARM (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ARMH\" title=\"ARM Holdings, plc\">ARMH</a>) has been started at Outperform by JMP.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1415762\" data-linked=\"A roundup of tech ratings changes\" data-tweet=\"$SAP $SAP $ERIC - A roundup of tech ratings changes https://seekingalpha.com/news/1415762-a-roundup-of-tech-ratings-changes?source=tweet\" data-url=\"https://seekingalpha.com/news/1415762-a-roundup-of-tech-ratings-changes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:07 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1415742\" data-ts=\"1384524323\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MJN\" target=\"_blank\">MJN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1415742-mead-johnson-rallies-on-china-policy-change\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mead Johnson rallies on China policy change</a></h4><ul>\n<li>Mead Johnson Nutrition (NYSE:<a href=\"https://seekingalpha.com/symbol/MJN\" title=\"Mead Johnson Nutrition Company\">MJN</a>) jumps <font color=\"green\">3%</font> before the bell.</li>\n<li>Likely behind the strength is China's move to loosen the one-child policy.</li>\n<li>The new policy <a href=\"http://www.theguardian.com/world/2013/nov/15/china-one-child-policy-abolish-labour-camps\" target=\"_blank\">allows couples</a> to have two children if one of the parents is an only child. Previously, both the mother and father had to be only children.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1415742\" data-linked=\"Mead Johnson rallies on China policy change\" data-tweet=\"$MJN - Mead Johnson rallies on China policy change https://seekingalpha.com/news/1415742-mead-johnson-rallies-on-china-policy-change?source=tweet\" data-url=\"https://seekingalpha.com/news/1415742-mead-johnson-rallies-on-china-policy-change\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1415722\" data-ts=\"1384524127\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GSE\" target=\"_blank\">GSE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1415722-gse-holdings-q3-eps-of-1_77-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GSE Holdings Q3 EPS of -$1.77, misses on revenue</a></h4><ul>\n<li>GSE Holdings (NYSE:<a href=\"https://seekingalpha.com/symbol/GSE\" title=\"GSE Holding\">GSE</a>): Q3 EPS of -$1.77 may not be comparable to $0.09 consensus.</li>\n<li>Revenue of $118M (-3% Y/Y) <font color=\"red\">misses by $6M</font>.</li>\n<li>Shares <font color=\"red\">-21.6%</font> premarket. (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1415722\" data-linked=\"GSE Holdings Q3 EPS of -$1.77, misses on revenue\" data-tweet=\"$GSE - GSE Holdings Q3 EPS of -$1.77, misses on revenue https://seekingalpha.com/news/1415722-gse-holdings-q3-eps-of-1_77-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/1415722-gse-holdings-q3-eps-of-1_77-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1415672\" data-ts=\"1384523630\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BTG\" target=\"_blank\">BTG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1415672-b2gold-volta-resources-to-combine\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">B2Gold, Volta Resources to combine</a></h4><ul>     <li>B2Gold (NYSEMKT:<a href=\"https://seekingalpha.com/symbol/BTG\" title=\"B2Gold Corp.\">BTG</a>) <font color=\"green\">+11.6%</font> premarket after signing a definitive arrangement agreement with Volta Resources relating  to the previously announced <a href=\"http://online.wsj.com/article/PR-CO-20131114-914565.html\" target=\"_blank\">combination of the two businesses</a>.</li>     <li>The acquisition of Volta will add to BTG's development portfolio an 81% interest in the Kiaka gold project in Burkina Faso and a 100% interest in two additional exploration projects in  the African country.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1415672\" data-linked=\"B2Gold, Volta Resources to combine\" data-tweet=\"$BTG - B2Gold, Volta Resources to combine https://seekingalpha.com/news/1415672-b2gold-volta-resources-to-combine?source=tweet\" data-url=\"https://seekingalpha.com/news/1415672-b2gold-volta-resources-to-combine\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:53 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1415632\" data-ts=\"1384523264\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BSPM\" target=\"_blank\">BSPM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1415632-biostar-pharmaceuticals-looks-for-encore-after-huge-gain-q3-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biostar Pharmaceuticals looks for encore after huge gain, Q3 report</a></h4><ul>\n<li>China-based  Biostar Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/BSPM\" title=\"Biostar Pharmaceutic\">OTC:BSPM</a>) rises <font color=\"green\">4%</font> premarket after posting Q3 results Thursday evening.<br>\n</li>\n<li>The company earned $0.03/share on revenue of $15M (+50% Y/Y). (PR)<br>\n</li>\n<li>Of note: BSPM rose <strong><font color=\"green\">60%</font></strong> during regular trading Thursday. </li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1415632\" data-linked=\"Biostar Pharmaceuticals looks for encore after huge gain, Q3 report\" data-tweet=\"$BSPM - Biostar Pharmaceuticals looks for encore after huge gain, Q3 report https://seekingalpha.com/news/1415632-biostar-pharmaceuticals-looks-for-encore-after-huge-gain-q3-report?source=tweet\" data-url=\"https://seekingalpha.com/news/1415632-biostar-pharmaceuticals-looks-for-encore-after-huge-gain-q3-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:47 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1415592\" data-ts=\"1384522736\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARNA\" target=\"_blank\">ARNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1415592-arena-pharmaceuticals-rises-on-wallachbeth-coverage\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arena Pharmaceuticals rises on WallachBeth coverage</a></h4><ul>\n<li>Arena Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ARNA\" title=\"Arena Pharmaceuticals, Inc.\">ARNA</a>) gets a <font color=\"green\">3.7%</font> premarket lift from an <a href=\"https://twitter.com/Briefingcom/status/401309897364471808\" target=\"_blank\">upbeat initiation</a> at WallachBeth.</li>\n<li>Price target is $9, representing upside of <font color=\"green\">76%</font> from Thursday's close.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1415592\" data-linked=\"Arena Pharmaceuticals rises on WallachBeth coverage\" data-tweet=\"$ARNA - Arena Pharmaceuticals rises on WallachBeth coverage https://seekingalpha.com/news/1415592-arena-pharmaceuticals-rises-on-wallachbeth-coverage?source=tweet\" data-url=\"https://seekingalpha.com/news/1415592-arena-pharmaceuticals-rises-on-wallachbeth-coverage\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1415582\" data-ts=\"1384522458\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FU\" target=\"_blank\">FU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1415582-fab-universal-calls-alfred-little-report-misleading-and-inaccurate\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FAB Universal calls Alfred Little report &quot;misleading and inaccurate&quot;</a></h4><ul>\n<li>FAB Universal (NYSEMKT:<a href=\"https://seekingalpha.com/symbol/FU\" title=\"FAB Universal Corp.\">FU</a>) calls the claims published in a <a href=\"https://seekingalpha.com/currents/post/1414032\" target=\"_blank\">short report </a>by Alfred Little \"misleading and inaccurate allegations.\"</li>\n<li>The company will \"as soon as possible, issue a public statement to refute these defamatory remarks.\"</li>\n<li>Shares <font color=\"red\">-6.7%</font> pre-market</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1415582\" data-linked=\"FAB Universal calls Alfred Little report &quot;misleading and inaccurate&quot;\" data-tweet=\"$FU - FAB Universal calls Alfred Little report &quot;misleading and inaccurate&quot; https://seekingalpha.com/news/1415582-fab-universal-calls-alfred-little-report-misleading-and-inaccurate?source=tweet\" data-url=\"https://seekingalpha.com/news/1415582-fab-universal-calls-alfred-little-report-misleading-and-inaccurate\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:34 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1415522\" data-ts=\"1384521951\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VNDA\" target=\"_blank\">VNDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1415522-vanda-extends-rally-in-premarket-trading\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vanda extends rally in premarket trading</a></h4><ul>\n<li>It's been a good week for shares of Vanda Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/VNDA\" title=\"Vanda Pharmaceuticals Inc.\">VNDA</a>) as both FDA staff and Ad Com panel members have smiled on the company's Non-24-Hour Disorder treatment <a href=\"https://seekingalpha.com/currents/search?query=tasimelteon\" target=\"_blank\">tasimelteon</a>.</li>\n<li>The shares are up <font color=\"green\">14%</font> premarket. If the gains carry over into regular trading, VNDA will have risen nearly <strong><font color=\"green\">120%</font></strong> since Monday.</li>\n<li>For perspective: As of Wednesday's close (the shares were halted on Thursday), the stock's gains since September 3 are just <font color=\"green\">8%</font>.</li>\n<li>See also: VNDA enjoys \"<a href=\"https://seekingalpha.com/currents/post/1414192\" target=\"_blank\">love-fest</a>\" at Ad Com</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1415522\" data-linked=\"Vanda extends rally in premarket trading\" data-tweet=\"$VNDA - Vanda extends rally in premarket trading https://seekingalpha.com/news/1415522-vanda-extends-rally-in-premarket-trading?source=tweet\" data-url=\"https://seekingalpha.com/news/1415522-vanda-extends-rally-in-premarket-trading\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1415452\" data-ts=\"1384521007\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HQCL\" target=\"_blank\">HQCL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1415452-hanwha-launches-70m-stock-offering-shares-minus-2_8-percent-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hanwha launches $70M stock offering, shares -2.8% premarket</a></h4><ul>\n<li>With Hanwha (HSOL) sporting a market cap of just $360M, the offering could increase its share count by 19%, if priced at current levels. (PR)</li>\n<li>The Chinese solar cell/module vendor ended Q3 with $171.5M in cash, and $791M in debt.</li>\n<li>\n<a href=\"https://seekingalpha.com/currents/post/1405922\" target=\"_blank\">Previous:</a> Hanwha falls after Q3 report, margins remain low</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1415452\" data-linked=\"Hanwha launches $70M stock offering, shares -2.8% premarket\" data-tweet=\"$HQCL - Hanwha launches $70M stock offering, shares -2.8% premarket https://seekingalpha.com/news/1415452-hanwha-launches-70m-stock-offering-shares-minus-2_8-percent-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/1415452-hanwha-launches-70m-stock-offering-shares-minus-2_8-percent-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1415362\" data-ts=\"1384520176\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLRD\" target=\"_blank\">TLRD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1415362-mens-wearhouse-lower-after-jos-a-bank-moves-on\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Men&#39;s Wearhouse lower after Jos. A Bank moves on</a></h4><ul> <li>Men's Wearhouse (MW) falls in early trading after Jos. A Bank officially <a href=\"https://seekingalpha.com/currents/post/1415152\" target=\"_blank\">terminates</a> its acquisition proposal.</li>\n<li>What to watch: Eminence Capital carries a lot of clout with its 9.8% stake in Men's Wearhouse and could push for new discussions between the two men's clothiers.</li> <li>MW <font color=\"red\">-1.9%</font> premarket.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1415362\" data-linked=\"Men&#39;s Wearhouse lower after Jos. A Bank moves on\" data-tweet=\"$TLRD - Men&#39;s Wearhouse lower after Jos. A Bank moves on https://seekingalpha.com/news/1415362-mens-wearhouse-lower-after-jos-a-bank-moves-on?source=tweet\" data-url=\"https://seekingalpha.com/news/1415362-mens-wearhouse-lower-after-jos-a-bank-moves-on\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1415132\" data-ts=\"1384511648\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1415132-eurozone-cpi-contracts-on-monthly-basis\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eurozone CPI contracts on monthly basis</a></h4><ul>   <li>As expected, Eurozone CPI dropped 0.1% on month in October vs +0.5% in September.</li>    <li>On year, inflation fell to +0.7% (also in line) vs +1.1% previously.</li>    <li>Core CPI +0.8% vs +1%.</li>    <li>Inflation fell further away from the ECB's target of just under 2%, possibly giving the bank even further room to cut interest rates to zero - although the German's would surely have <a href=\"https://seekingalpha.com/currents/post/1414302\" target=\"_blank\">something to say about that</a> - following the <a href=\"https://seekingalpha.com/currents/post/1394852\" target=\"_blank\">surprise reduction</a> last week to 0.25%. (PR)</li>    <li>EU stocks are mixed heading towards midday following the Yellen-induced rally yesterday, with the EU Stoxx 50 <font color=\"red\">-0.1%</font>, London <font color=\"green\">+0.3%</font>, Paris flat, Frankfurt flat, Milan <font color=\"red\">-0.7%</font> and Madrid <font color=\"red\">-0.1%</font>.</li>     <li>ETFs - Stocks: <a href=\"https://seekingalpha.com/symbol/ezu\" title=\"iShares MSCI EMU ETF\">EZU</a>, <a href=\"https://seekingalpha.com/symbol/vgk\" title=\"Vanguard FTSE Europe ETF\">VGK</a>, <a href=\"https://seekingalpha.com/symbol/fez\" title=\"SPDR EURO STOXX 50 ETF\">FEZ</a>, <a href=\"https://seekingalpha.com/symbol/epv\" title=\"ProShares UltraShort FTSE Europe ETF\">EPV</a>, <a href=\"https://seekingalpha.com/symbol/iev\" title=\"iShares Europe ETF\">IEV</a>,  <a href=\"https://seekingalpha.com/symbol/adru\" title=\"BLDRS Europe 100 ADR Index ETF\">ADRU</a>, <a href=\"https://seekingalpha.com/symbol/fep\" title=\"First Trust Europe AlphaDEX ETF\">FEP</a>, <a href=\"https://seekingalpha.com/symbol/fdd\" title=\"First Trust Dow Jones STOXX European Select Dividend 30 Index ETF\">FDD</a>, <a href=\"https://seekingalpha.com/symbol/upv\" title=\"ProShares Ultra FTSE Europe ETF\">UPV</a>, <a href=\"https://seekingalpha.com/symbol/epv\" title=\"ProShares UltraShort FTSE Europe ETF\">EPV</a>, <a href=\"https://seekingalpha.com/symbol/dfe\" title=\"WisdomTree Europe SmallCap Dividend ETF\">DFE</a>, <a href=\"https://seekingalpha.com/symbol/feu\" title=\"SPDR STOXX Europe 50 ETF\">FEU</a>, <a href=\"https://seekingalpha.com/symbol/feeu\" title=\"Barclays ETN+ FI Enhanced Europe 50 ETN\">FEEU</a>. Bonds: <a href=\"https://seekingalpha.com/symbol/eu\" title=\"WisdomTree Euro Debt ETF\">EU</a>. Euro: <a href=\"https://seekingalpha.com/symbol/fxe\" title=\"CurrencyShares Euro Trust ETF\">FXE</a>, <a href=\"https://seekingalpha.com/symbol/ero\" title=\"iPath EUR/USD Exchange Rate ETN\">ERO</a>, <a href=\"https://seekingalpha.com/symbol/ule\" title=\"ProShares Ultra Euro ETF\">ULE</a>, <a href=\"https://seekingalpha.com/symbol/urr\" title=\"Market Vectors Double Long Euro ETN\">URR</a>, <a href=\"https://seekingalpha.com/symbol/euo\" title=\"ProShares UltraShort Euro ETF\">EUO</a>, <a href=\"https://seekingalpha.com/symbol/drr\" title=\"Market Vectors Double Short Euro ETN\">DRR</a>, <a href=\"https://seekingalpha.com/symbol/eufx\" title=\"ProShares Short Euro ETF\">EUFX</a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"1415132\" data-linked=\"Eurozone CPI contracts on monthly basis\" data-tweet=\"$EZU $VGK $FEZ - Eurozone CPI contracts on monthly basis https://seekingalpha.com/news/1415132-eurozone-cpi-contracts-on-monthly-basis?source=tweet\" data-url=\"https://seekingalpha.com/news/1415132-eurozone-cpi-contracts-on-monthly-basis\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:34 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1415122\" data-ts=\"1384510805\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1415122-chinese-shares-rise-on-optimism-about-reform\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chinese shares rise on optimism about reform</a></h4><ul>   <li>The Shanghai Composite has closed <font color=\"green\">+1.7%</font> and the Hang Seng <font color=\"green\">+1.65%</font> after senior Chinese economic official Yang Weimin said the government had approved a <a href=\"http://sinosphere.blogs.nytimes.com/2013/11/15/beijing-talks-up-economic-reform/\" target=\"_blank\">20,000-word document</a> at the Third Plenum this week about reforms involving 15 sectors.</li>    <li>\"Every sentence is reform, every word packs a punch,\" Yang said. The document \"seizes onto the most deep-seated problems in reforming our country\u2019s economic system.\"</li>    <li>Investors were disappointed earlier this week by the lack of details in the government's initial pronouncements about its reform agenda.</li>\n<li>ETFs - Stocks: <a href=\"https://seekingalpha.com/symbol/fxi\" title=\"iShares China Large-Cap ETF\">FXI</a>, <a href=\"https://seekingalpha.com/symbol/gxc\" title=\"SPDR S&amp;P China ETF\">GXC</a>, <a href=\"https://seekingalpha.com/symbol/pgj\" title=\"PowerShares Golden Dragon China Portfolio ETF\">PGJ</a>, <a href=\"https://seekingalpha.com/symbol/yao\" title=\"Guggenheim China All-Cap ETF \">YAO</a>, <a href=\"https://seekingalpha.com/symbol/fchi\" title=\"iShares FTSE China (HK-Listed) Index ETF\">FCHI</a>, <a href=\"https://seekingalpha.com/symbol/pek\" title=\"Market Vectors China ETF \">PEK</a>, <a href=\"https://seekingalpha.com/symbol/caf\" title=\"Morgan Stanley China A Share Fund\">CAF</a>, <a href=\"https://seekingalpha.com/symbol/yxi\" title=\"ProShares Short FTSE China 25 ETF\">YXI</a>, <a href=\"https://seekingalpha.com/symbol/xpp\" title=\"ProShares Ultra FTSE China 25 ETF\">XPP</a>, <a href=\"https://seekingalpha.com/symbol/fxp\" title=\"ProShares UltraShort FTSE China 25 ETF\">FXP</a>, <a href=\"https://seekingalpha.com/symbol/mchi\" title=\"iShares MSCI China ETF\">MCHI</a>, <a href=\"https://seekingalpha.com/symbol/yinn\" title=\"Direxion Daily China Bull 3x Shares ETF\">YINN</a>, <a href=\"https://seekingalpha.com/symbol/yang\" title=\"Direxion Daily China Bear 3x Shares ETF\">YANG</a>, <a href=\"https://seekingalpha.com/symbol/tchi\" title=\"RBS China Trendpilot ETN\">TCHI</a>, <a href=\"https://seekingalpha.com/symbol/chxf\" title=\"WisdomTree China Dividend ex-Financials ETF\">CHXF</a>, <a href=\"https://seekingalpha.com/symbol/kfyp\" title=\"KraneShares CSI China Five Year Plan ETF\">KFYP</a>, <a href=\"https://seekingalpha.com/symbol/hao\" title=\"Guggenheim China Small Cap ETF \">HAO</a>, <a href=\"https://seekingalpha.com/symbol/ecns\" title=\"iShares MSCI China Small-Cap ETF\">ECNS</a>. Bonds: <a href=\"https://seekingalpha.com/symbol/dsum\" title=\"PowerShares Chinese Yuan Dim Sum Bond Portfolio ETF\">DSUM</a>, <a href=\"https://seekingalpha.com/symbol/chlc\" title=\"Market Vectors Renminbi Bond ETF\">CHLC</a>. Currency: <a href=\"https://seekingalpha.com/symbol/cny\" title=\"Market Vectors Chinese Renminbi/USD ETN\">CNY</a>, <a href=\"https://seekingalpha.com/symbol/cyb\" title=\"WisdomTree Chinese Yuan ETF\">CYB</a>, <a href=\"https://seekingalpha.com/symbol/fxch\" title=\"CurrencyShares Chinese Renminbi Trust ETF\">FXCH</a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"1415122\" data-linked=\"Chinese shares rise on optimism about reform\" data-tweet=\"$FXI $GXC $PGJ - Chinese shares rise on optimism about reform https://seekingalpha.com/news/1415122-chinese-shares-rise-on-optimism-about-reform?source=tweet\" data-url=\"https://seekingalpha.com/news/1415122-chinese-shares-rise-on-optimism-about-reform\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1415112\" data-ts=\"1384509890\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1415112-japanese-shares-continue-to-rise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Japanese shares continue to rise</a></h4><ul>    <li>The Nikkei 225 has <font color=\"green\">risen 1.95%</font> to close at a <a href=\"http://www.cnbc.com/id/101200887\" target=\"_blank\">six-month high</a> of 15,165.92, which also represents a 7.7% gain since last Friday - the best weekly performance this year.</li>    <li>As has often been the case with these things, the yen has traveled in the opposite direction, with the USD-JPY <font color=\"green\">+0.3%</font> to ¥100.36.</li>    <li>The USD-JPY appears to still be feeling the effects of Finance Minister Taro Asa saying that the government still has the option of <a href=\"https://seekingalpha.com/currents/post/1412382\" target=\"_blank\">intervening in currency markets</a> to keep the yen down.</li>    <li>Janet Yellen's dovish comments at her confirmation hearing have been soothing stock markets that have been concerned about Fed tapering, although shouldn't her remarks be helping to weaken the dollar?</li>     <li>ETFs - Stocks: <a href=\"https://seekingalpha.com/symbol/ewj\" title=\"iShares MSCI Japan ETF\">EWJ</a>, <a href=\"https://seekingalpha.com/symbol/nky\" title=\"Precidian MAXIS Nikkei 225 Index ETF\">NKY</a>, <a href=\"https://seekingalpha.com/symbol/ewv\" title=\"ProShares UltraShort MSCI Japan ETF\">EWV</a>, <a href=\"https://seekingalpha.com/symbol/ezj\" title=\"ProShares Ultra MSCI Japan ETF\">EZJ</a>, <a href=\"https://seekingalpha.com/symbol/itf\" title=\"iShares Japan Large-Cap ETF\">ITF</a>, <a href=\"https://seekingalpha.com/symbol/jsc\" title=\"SPDR Russell/Nomura Small Cap Japan ETF\">JSC</a>, <a href=\"https://seekingalpha.com/symbol/jpp\" title=\"SPDR Russell/Nomura PRIME Japan ETF\">JPP</a>, <a href=\"https://seekingalpha.com/symbol/dxj\" title=\"WisdomTree Japan Hedged Equity ETF\">DXJ</a>, <a href=\"https://seekingalpha.com/symbol/scj\" title=\"iShares MSCI Japan Small-Cap ETF\">SCJ</a>, <a href=\"https://seekingalpha.com/symbol/dfj\" title=\"WisdomTree Japan SmallCap Dividend ETF\">DFJ</a>, <a href=\"https://seekingalpha.com/symbol/fjp\" title=\"First Trust Japan AlphaDEX ETF\">FJP</a>, <a href=\"https://seekingalpha.com/symbol/jpnl\" title=\"Direxion Daily Japan Bull 3x Shares ETF\">JPNL</a>, <a href=\"https://seekingalpha.com/symbol/jpns\" title=\"Direxion Daily Japan Bear 3x Shares ETF\">JPNS</a>, <a href=\"https://seekingalpha.com/symbol/dxjs\" title=\"WisdomTree Japan Hedged SmallCap Equity ETF\">DXJS</a>. Bonds: <a href=\"https://seekingalpha.com/symbol/jgbt\" title=\"PowerShares DB 3x Japanese Government Bond Futures ETN\">JGBT</a>, <a href=\"https://seekingalpha.com/symbol/jgbl\" title=\"PowerShares DB Japanese Government Bond Futures ETN\">JGBL</a>, <a href=\"https://seekingalpha.com/symbol/jgbs\" title=\"PowerShares DB Inverse Japanese Govt. Bond Futures ETN\">JGBS</a>, <a href=\"https://seekingalpha.com/symbol/jgbd\" title=\"PowerShares DB 3x Inverse Japanese Govt. Bond Futures ETN\">JGBD</a>. Currency: <a href=\"https://seekingalpha.com/symbol/fxy\" title=\"CurrencyShares Japanese Yen Trust ETF\">FXY</a>, <a href=\"https://seekingalpha.com/symbol/jyn\" title=\"iPath JPY/USD Exchange Rate ETN\">JYN</a>, <a href=\"https://seekingalpha.com/symbol/ycl\" title=\"ProShares Ultra Yen ETF\">YCL</a>, <a href=\"https://seekingalpha.com/symbol/ycs\" title=\"ProShares UltraShort Yen ETF\">YCS</a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"1415112\" data-linked=\"Japanese shares continue to rise\" data-tweet=\"$EWJ $NKY $EWV - Japanese shares continue to rise https://seekingalpha.com/news/1415112-japanese-shares-continue-to-rise?source=tweet\" data-url=\"https://seekingalpha.com/news/1415112-japanese-shares-continue-to-rise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:04 AM </div></div></li>","count":44,"message":null,"success":true,"today":{"start":1576818000,"end":1576904399,"str":"Friday, December 20, 2019"},"yesterday":{"start":1576731600,"end":1576817999}}